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Evaluation of vascular calcinosis risk factors in patients on maintenance
hemodialysis. A. Atik, S. Benelmoufok, H. Renaud, M. Hervé, P.
Morinihre, and A. Fournier. Service de NEphrologie, CHU A miens,
Amiens, France. Lateral x-rays of abdominal aorta and antero posterior
x-rays of the pelvis were performed in 24 uremic patients (age range, 24
to 66 years) just before the beginning of chronic hemodialysis and then
annually during 3 years. The length of their vascular calcifications on
the aorta and ilio femoral arteries was measured by three observcrs at
three different occasions to provide a mean of nine measurements.
Calcifications were present initially or occurred during the 3 years in
seven men and in seven out of the 16 women. Covariance analysis was
performed to assess the link between the relative increase of the
calcifications within 3 years IC3-CO and various biological pa-
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rameters. This analysis shows that male sex is atone a determinant risk
factor (Cc = 1.97, P < 0.01). Age plays a significant helping role only in
the male (Cc = 1.99, P < 0.01) whereas its role has only borderline
significance in the female (Cc = 1.54, P < 0.06). Diastolic blood
pressure (P < 0.05) but not the systolic BP (P = 0.08), the triglycerides(P C 0.05) but not the total cholesterol or lipids are covariant with
calcification increase. Covariance exists at a borderline significance
with plasma calcemia (P = 0.08), phosphate (P = 0.12) and blood
glucose (P C 0.010). No link exists for alkaline phosphatase, taken as an
index of PTH, nor for blood uric acid or the doses of CaCO3. Study of
combinations of two risk factors by multiple covariance analysis shows
that the multiplicating factors of the risk are the following:
Diastolic BP P Calcium BI glucose Triglycerides
Diastolic BP — 2.24* 2.05* 2.39*
P Calcium — — 2.79** 2.79**
Blglucose — — — 2.19*
For triple associations, this multiplicating factor is 3.25** for diastolic
BP + plasma calcium + triglycerides; 2.90** for diastolic BP + plasma
calcium + blood glucose; 2.5 for diastolic BP + blood glucose +
triglycerides and 1.98 for plasma calcium + triglycerides + blood
glucose. It is 4.54 (P C 0.002) for the association of the four factors. In
conclusion, arterial calcinosis of hemodialyzed patients is favored
independently and therefore cumulatively in both sexes by diastolic BP,
triglycerides and plasma calcium, and phosphate and glucose. Male sex
plays an independent role; age is the significant helping factor only in
the male sex.
Renal amyloidosis complicating psoriatic arthritis. A. Bruet, D. Hil-
lion, and J. P. Fendler. Service de Medecine Interne ci Néphrologie,
CHI Poissy, Poissy, France. Amyloidosis (AML) is an unusual com-
plication of psoriatic arthritis (PA) contrary to other chronic inflamma-
tory arthritis. We reported the case of a 35-year-old man, in whom the
first joint involvements appeared at 18 years of age and which were
attributed to a PA 10 years later when typical skin lesions occurred. It
was a psoriatic spondyloarthritis associated with peripheral arthritis
(positive HLA B 27). Severe articular disability was not influenced by
nonsteroidal anti-inflammatory drugs and gold therapy. Renal involve-
ment, nephrotic syndrome (serum albumin, 1.98 g/dl; proteinuria, 8 g/24
hr) with renal insufficiency (serum creatinine, 548 zmoles/liter) revealed
AML and was confirmed histologically: Large glomerular amyloid
deposits were present, as well as vascular and peritubular deposits.
Death occurred within 10 months after 3 months in hemodialysis. AML
complicating PA suggests several comments. There is a male predom-
inance (5/1) not found in uncomplicated PA. Severe joint involvements
are common (sacro-ilitis and spondilitis in 60% of the cases) as well as
cutaneous involvement (extensive forms, pustular or erythrodermic
psoriasis). AML appears on the average 10 years after the onset of
arthritis and 15 years after the initial cutaneous signs which precedes
arthritis in 75% of the cases. Nearly constant renal involvement proven
histologically usually reveals AML and rarely alimentary tract involve-
ment. Prognosis is severe, a single case report referred to the improve-
ment of a nephrotic syndrome without complete disappearance of
proteinuria in a patient whose remission of PA was obtained. Protein
AA is demonstrated in several cases. The rare occurrence of AML in
the course of PA is unexplained and may be due to genetic factors or
heterogeneity of the serum precursor substance (SAA).
Renal amyloidosis and transplantation: five patients. R. Cuvelier, Y.
Pirson, J. P. Cosyns, J. P. Squifflet, G. P. J. Alexandre, and C. van
Ypersele de Strihou. University of Loavain Medical School, Cliniques
Universitaires St-Luc, Brussels, Belgium. The usefulness of renal
transplantation (RT) in the treatment of amyloid (A) renal failure
remains a moot point. Between June 1973 and June 1984 five patients
(three females, two males) with a mean age of 27 years (range, 15 to 33)
were transplanted (living donor, one; cadaver, four) for A renal failure
due to familial mediterranean fever (one patient), Crohn ileitis (one
patient), and apparently primary in the three others. Immunosuppres-
sive therapy (azathioprine-prednisone, four patients; cyclosporine-
prednisone, one patient) was associated in two patients with colchicine
(0.5 to 2 mg/day) from RT onwards. One patient died from cardiac
arrhythmia associated with dehydration more than 10 years after RT
with normal renal function. The four others are alive 2 to 57 (mean, 30)
months post-R with a functioning graft (serum creatinine 0.7 to 3.6;
mean, 1.9 mg/dl). Three patients had no rejection episode; no major
infectious complications occurred. Further development of A was
demonstrated by the appearance of a goiter in three patients and
proteinuria (one patient) due to progressive A deposition in the graft
documented histologically 72 and 126 months post-RT. Graft biopsy
performed in two other patients 17 and 36 months post-RT failed to
disclose A deposits. We conclude that RT has a good prognosis in A
renal failure despite extrarenal progression of the disease and the risk of
recurrence in the graft.
Evaluation of two strategies of hemodiafiltration (HDF). J. F. de
Frémont, P. Faguer, M. Tolani, P. Morinihre, N. K. Man, and A.
Foamier. Clinique Saint-Come, Compihgne; HOpital Necker, Paris;
CHU A miens, Amiens, France. Hemofiltration (HF) with 10 liters of
substitution fluid (SF) per run allows long-term survival of uremic
patients, but their levels of small (SM) and middle molecules (MM)
remain high. To improve these results, three patients previously in HF
with 10 liters of SF were treated with HDF. To assess separately the
efficiency of the two procedures, a hemofilter and a dialyser were used
successively. Within 2 hr, 10 liters of SF were administered and 30 liters
of an acetate dialysate were delivered during the 3 first months; during
the following 3 months, 60 liters were delivered during the same time.
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At the end of each period of treatment blood urea, plasma (P),
creatinine, P phosphate, P aluminium, and P middle molecule b4.2 were
evaluated during the first run of the week. The mass transfer per run
was also calculated. The plasma study showed:
N = 9 HF 10 liters HDF 30 liters HDF 60 liters
Creatinine,
/2moles/liter 1800 215 1430 200 1316 137
Urea,
mmoles/iiter 47 5 33 5 30 4
Phosphate,
mmoles/Iiter 1.7 0.4 1.9 0.5 1.9 0.4
Aluminium,
moles/iiter 4.6 0.3 2.3 0.9 1.8 0.8
b4.2, mg/liter 7.2 2 7.7 2
The mass transfer increased by 4, 3, and 17% for creatinine, urea,
phosphate, and aluminium by changing HDF from 30 to 60 liters. In
conclusion, (1) short HDF improves levels of small molecules com-
pared to HF alone but middle molecule b4.2 levels remain in the same
range as HF with 10 liters of SF. (2) Mass transfer moderately improves
with HDF, 60 liters, compared to HDF, 30 liters. (3) Plasma aluminium
was improved by HDF, but this point needs further evaluation.
A new recent case of Muckle and Wells syndrome (MWS): A seldom.
occurring cause of renal amyloidosis. J. L. Gamier, H. My, S. Colon, P.
Deteix, and J. Traeger. Hôpital Edouard-Herriot, Pavilion P, Lyon,
France. A recent familial case of MWS was observed in a 32-year-old
woman, a native of the East of France. Her paternal grandfather,
affected by deafness, died at the age of 45, her father presented many
attacks of inflammatory joint pains and cutaneous rash; he was affected
by deafness and he died when 56 years old with a nephrotic syndrome
and renal failure. Our patient suffered from recurrent joint pains since
she was 11 (not improved with steroid therapy), abdominal pains,
mainly at night since the age of 20, nonirritating cutaneous rash on her
legs and abdomen. She complained with recent paresthesiae of her legs
and conjunctivitis. Progressive bilateral defective hearing has been
investigated 5 years (nervous deafness) and had become worse in year.
She was affected by infertility without amenorrhea or loss of libido. She
was seen as an outpatient in May 1984, 2 months after bilateral ankle
edema became apparent. Proteinuria (24 hr) was 2.4 g, renal function
was normal, complement components, IgE, and ALSO titer levels were
within the normal range; immune complexes, antinuclear antibody and
rheumatoid factor were not detected. Electromyography showed an
axonal peripheral neuropathy. A kidney biopsy specimen showed
amyloid deposits identified within the glomerulus and the wall of the
small arteries (seen in the perirenal fat tissue) evoking a generalized
amyloidosis. Skin and nerve biopsy specimens were negative without
any amyloid deposition. Infertility could be due to luteal deficit
(gonadotrophins and LHRF test values were normal). The caryotype
was normal. DR HLA antigen typing was inconclusive because of
overlapping reactions, and OKT4/OKT8 ratio was increased to 2.9%
(OKT3 = 65%, OKT4 = 52%, OKT8 = 18%); both gave evidence for
lymphocyte activation. Our patient received 1 mg colchicine daily. This
is a new case of the MWS which mimics familial Mediterranean fever.
Serum AA protein determination and its deposition within the amyloid
lesions could be an interesting subject of study.
Treatment of advanced chronic uremia with ketoanalogs (KA) of
essential aminoacids (AA): A prospective open study. P. Jungers, P.
Chauveau, B. Lebkiri, C. Ciancioni, P. Parvy, N. K. Man and J.
Crosnier. Departments of Nephrology and Biochemistry and INSERM
Unit 90, Necker Hospital, Paris, France. Maintenance dialysis exposes
to high mortality and morbidity in aged and/or high vascular risk
patients. Thus, from June 1981 to July 1984, we treated 16 ambulatory
chronic uremic patients (ten male, six female), aged (mean 1 SD) 66.2
13 years, after informed consent, with a KA preparation (Ketosteril*,
1 tablet per 6 kg body wt/day) combined with a low protein diet (0.5
g/kg/day of unselected proteins). Before KA, the creatinine clearance
was 8.4 3.3 mI/mm, plasma creatinine (Pcr) and urea (Pu) concentra-
tions were 746 139 moles/liter (range, 550 to 910) and 33.9 8.4
mmoles/liter, respectively. Urinary urea (Uu) was 276 130
mmoles/day, body weight was 63.4 13.8 kg. Mean KA dose was 10.6
1.9 tablet per day. Tolerance was good in all patients but one who
stopped KA after 2 months; five patients still are on KA at 7, 11, 19, 27,
and 36 months; six started dialysis after 3, 7, 10, 12, 17, and 18 months;
two interrupted KA after 12 and 14 months; two died from vascular
accident at 7 and 9 months. Thus, 8 of 16 patients survived 12 months
or more with KA. After 1 month (N = 16) and 12 months (N = 8) on
KA, PCr decreased to 686 135 and 685 130 moles/liter, Pu to 25.7
7.8 and 25.9 8.6 mmoles/liter(P <0.01) and Uu to 195 68 and 175
70 mmoles/day (P < 0.05), respectively. Body weight, arm muscle
circumference and albuminemia varied by less than 5% of initial values.
The plasma "middle molecule" (b4-2 peak) concentration never ex-
ceeded 4 mg/liter. Less blood transfusions were needed in nine patients.
Calcemia (before/during KA: 2.28 0.07 vs. 2.32 0.10 mmoles/liter)
and phosphatemia (1.64 0.23 vs. 1.36 0.21 mmoles/liter) were
controlled by lower doses of 25 (OH) D and Al (OH)3. Plasma
concentration of branched-chain AA (300 78 vs. 302 68
jzmoles/liter), essential/non-essential AA ratio (0.45 0.11 vs. 0.51
0.08) and valine/glycine ratio (0.62 0.20 vs. 0.63 0.25) did not
significantly improve but remained in the range observed in uremic
patients treated by 3 dialysis sessions per week. We conclude that KA
combined with animal protein restriction may offer a valuable alterna-
tive to maintenance dialysis in compliant patients with advanced
chronic uremia, especially in the elderly and in patients with high
vascular risk.
Membranoproliferative glomerulonephritis (MPGN) is disappearing in
France: Epidemiologic data on 1231 patients with primary chronic
glomerulonephritis. P. Jungers, D. Forget, D. Droz, L. H. Noel, andJ.
P. Grunfeld. Department of Nephrology and INSERM Unit 25, Necker
Hospital, Paris, France. Three years ago, we reported a progressive
reduction in the incidence of MPGN observed at Necker Hospital since
the end of the last decade. This tendency has been confirmed during the
subsequent 3 years. Our present study concentrates on 1231 patients
referred to Necker Hospital from 197l to 1983, in whom primary
chronic glomerulonephritis (GN) was demonstrated on renal biopsy
studied by light microscopy and immunofluorescence. Since the inflec-
tion of the MPGN incidence curve occurred at the end of 1976, two
periods were compared (period 1, 197 1—76, 651 patients; period 2,
1977—83, 580 patients). The mean annual incidence of the different types
of GN varied as follows:
Type of GN
1971—76 (1)
No/year (%)
1977—83 (2)
No/year (%) test
MPGN (total)
France
Maghreb and
Africa
Membranous GN
IgA GN
Minimal change NS
and focal
hyalinosis
Other and
unclassified
17.5 (16.1%)
12 (11.1%)
4.1 (3.8%)
18.5 (16.9%)
31.3 (29%)
19.2 (17.8%)
22 (20.2%)
6.6 (7.9%)
3 (3.6%)
3.6 (4.3%)
18.6 (22.4%)
29.7 (36%)
19.4 (23.4%)
8.6 (10.3%)
P < 0.001
P < 0.001
NS
NS
NS
NS
NS
Total GN per year 108.5 (100%) 82.9 (100%)
A highly significant decrease of the annual incidence of MPGN was
observed from periods 1 to 2 (P < 0.001), whereas the mean annual
incidence and respective proportion of all other types of chronic GN did
not significantly vary. The decrease in MPGN incidence was only
observed in patients born and living in France, but both absolute and
relative frequency of MPGN were unchanged in patients referred from
Maghreb, Antilles, or Africa. The decrease in MPGN in France may be
compared with the decreased incidence of rheumatic heart disease
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during the past decade in industrialized countries, whereas MPGN and
rheumatic fever still are frequent in developing countries. As MPGN is
the variety of chronic GN most frequently leading to endstage renal
failure, these epidemiologic data are argument for extending prophy-
laxis of streptococcal infections.
Abdominal fat tissue aspirate in human amyloidosis. C. Orfila, P.
Giraud, A. Modesto, and J. M. Soc. /NSERM Unit 133, Faculté de
Médecine, Toulouse Rangueil, France. Abdominal fat tissue aspiration
is a method previously described and used to diagnose amyloidosis.
This method was used in seven patients with an amyloidosis proven by
biopsy: three with AA form (patients 1, 2, and 3), two with familial
Mediterranean fever AA (4 and 5), two with primary form AL (im-
munocyte dyscrasia, 6 and 7). In one patient with Bence-Jones protein-
uria, AL amyloidosis was suspected strongly (patient 8). Abdominal fat
tissue aspirate was studied by light microscopy using Congo red (CR)
staining and green birefringence with polarizing microscope by indirect
immunofluorescence with anti-AA protein antiserum and by electron
microscopy (EM).
Fat aspirate
Type of Congo
----- Other biopsy sites
--
Patients amyloidosis red AA EM Positive Negative
+ + — M
- - - K,J,R
AA + + + K
+ — — M
— S
+ — S
— + — S
Saint-Cloud, Centre d'HErnodialyse, C.H.J. Montreuil, France. To the
increasing list of complications due to absorption of Al by
hemodialyzed patients, we can add Al and Mg urate renal lithiasis in
subjects without a previous history of urolithiasis. Our first case was a
31-year-old man dialyzed since May 1982 for membranoproliferative
glomerulonephritis. Diuresis was 1000 ml/24 hr; he received Al hydrox-
ide 6 g/day. In February 1983 he eliminated a 2-mm stone, polyhedric,
grey-brown, smooth, hard, and homogenous. Infrared analysis showed
a composition of an unknown nature, whose spectral profile evoked a
uratic structure, confirmed by the microchemical analysis, which also
showed the presence of Mg. The infrared spectra was not the one of a
classical Mg urate, and according to the unusual clinical context, we
suspected the presence of Al in the stone. Elemental study by ionic
microprobe and EDAX confirmed the presence of Al as dominant
cation. This stone is thus composed of a complex urate of Al and Mg
and is not an association of these two urates. We have not found such
a case of stones induced by Al in the literature, but we have since
detected two other cases: (1) One patient had an acute interstitial
tubulonephritis of unknown origin, complicated by renal failure and
nephrocalcinosis. He has been treated by Al salts for 2 years and has
eliminated mixed stones of whewellite, Al, and Mg urate. (2) The other
patient, aged 22, was treated by Al hydroxyde during a whole year and
dialyzed for only some months; his stone was made of Al and Mg urate,
with a heavy quantity of proteins, and a small quantity of uric acid.
Urolithiasis occurs in 4% of dialyzed patients. Most often the patients
are males. The stones are small and contain calcium oxalate monohy-
drate (whewellite). In patients with preserved diuresis, urinary oxalate
R excretion often remains in a normal range during a long time, whereas
urinary calcium is always very low, which provokes an increase of
Ox/Ca ratio. In vitro a high Ox/Ca ratio induces monohydrate calcium
R oxalate crystallization. This feature could explain the formation of
whewellite stones in hemodialyzed patients.
8 AL? + - -
Abbreviations: M, bone marrow; K, kidney; J, jujunum; R, rectum; 5,
skin. In conclusion, Congo red staining of abdominal fat allowed the
detection of amyloidosis in six of eight patients. AA protein was present
in four patients and amyloid fibrils were observed in two patients by
EM. Although by IF and EM, amyloidosis was demonstrated less
frequently (perhaps because of the few materials examined), it seems
that the Congo red staining of abdominal fat is a simple and sensitive
method which can be used in patients who have a risk of bleeding or
other problems.
Study of human renal amyloidosis by immunolluorescence (IF). C.
Orfila, J. Rakotoarivony, A. Modesto, and J. M. Suc. INSERM Unit
133, Faculté de Médecine, Toulouse Rangueil, France. Twenty-two
renal biopsy specimens from patients with amyloidosis were studied by
IF. In six patients amyloidosis was associated with immunocyte
dyscrasia (AL) and in 16 patients amyloidosis was "secondary" (AA)
associated to pulmonary (three patients) or peritoneal (one patient)
tuberculosis, chronic infection (seven patients), rheumatoid arthritis
(two patients), or carcinoma (three patients). By IF study, deposits
were homogeneous in mesangial nodules and along glomerular base-
ment membranes. An overall study showed that immunoglobulins and
C3 deposits were observed in 18 patients and kappa and lambda light
chain deposits were present in 18 and IS patients, respectively. In
immunocyte dyscrasia, immunoglobulin and light-chain deposits in
glomeruli and tubular casts corresponded closely to paraprotein. The
amyloid P (AP) component was observed always in glomeruli and was
observed frequently in arterioles. AP component deposits showed a
nodular and characteristic pattern. AA protein was observed in 11
patients with "secondary" amyloidosis AA and in one patient with
"primary" amyloidosis AL. Various characteristics were observed
among various types of amyloidosis, but a consistent pattern did not
appear. It is difficult to determine the pathogenesis of this disease.
Nevertheless, IF study of AA protein can be helpful in diagnosis of AA
or AL amyloidosis.
Aluminium (Al) and magnesium (Mg) urate lithiasis: An unrecognized
complication of aluminium salt treatment in chronic hemodialysis. R. J.
Reveillaud, M. Dandon, andf. P. Adhemar. Laboratoire Cristal, C. H.
Legiondlla pneumophila outbreak in a department of nephrology. P.
Vereerstraeten, J. C. Stolear, E. Schoutens-Serruys, J. P. Thys, C.
Liesnard, F. Rost, P. Kinnaert, and C. Toussaint. Cliniqnes
Universitaires de Bruxelles, Hôpital Erasme, Brussels, Belgium. Be-
tween January 1, 1983, and April 30, 1984, 17 episodes of type 1
Legionella pneumophila (LP) pneumonia were observed in the wards of
a department of nephrology. The infection followed high-dose im-
munosuppression for kidney graft rejection (31 episodes) or for sys-
temic diseases with renal involvement (four patients). The overall
incidence of LP pneumonia was 49%. Severe hypoxemia was observed
in 8 of 17 patients (two deaths). The etiologic diagnosis was established
by serology and/or by culture and/or antigen identification by direct
immunofluoreseence in bronchial secretions with the following respec-
tive yields: 93, 56, and 29%. From July 9, 1983, to May 15, 1984, type
1 LP was detected intermittently in 35% of tapwater samples obtained
at various outlets in the department of nephrology as well as in other
wards of the hospital. Between January 1 and June 30, 1983, 12 cases of
LP pneumonia followed 26 episodes of high-dose immunosuppression
instituted in 23 kidney graft rejections and three connective tissue
diseases (incidence 46%). Between July 1, 1983, and April 30, 1984,
erythromyein prophylaxis was associated regularly with 39 other epi-
sodes of high-dose immunosuppression (graft rejection, 35; vasculitis,
two; multiple myeloma, two patients); no LP pneumonia was recorded.
During the same period, erythromycin prophylaxis was not applied to
nine patients undergoing severe immunosuppression (eight graft rejec-
tions, one sarcoidosis), and five LP pneumonia occurred. Erythromycin
thus affords very efficient protection to immunocompromised patients
treated in an LP-contaminated hospital. This prophylaxis is recom-
mended highly until proper measures are taken to eradicate LP orga-
nisms from the water supply system.
Appearance of generalized amyloidosis (AML) in a patient on regular
dialysis treatment (RTD). J. Villeboeuf, Y. Hillion, T. Haas, N. Simon,
and D. Hillion, CHI Poissy, Poissy, France. A 62-year-old woman was
on RTD for 12 years. In 1981, removal of a sacroeoccygeal cyst led to
the discovery of subcutaneous deposits with the histochemieal charac-
teristics of amyloid. There were no clinical signs of carpal tunnel
syndrome, nor generalized AML. Monoclonal gammapathy was absent.
In 1982, bone biopsy and parathyroideetomy were performed; no
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amyloid deposits were found in the tissues. In 1983, during a routine
examination a stage I cancer of cervix uteri was found and treated by
irradiation. In 1983, spontaneous hemarthrosis of the knees, ankles, and
wrists occurred. Large amyloid deposits were found in the synovial
biopsy. In 1984, a massive digestive hemorrhage necessitated a lapa-
rotomy: There were no metastases, the bleeding originated in the
terminal ileum which was excised; a liver biopsy was also performed.
Large amyloid deposits were found in the ileal submucosa and
subserosa, and smaller deposits were found in portal spaces. Using the
Wright technique, potassium permanganate treatment eliminated
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Congo red stainability. This is a new case of generalized AML in a
patient on RTD. The successive discovery of the deposits over a period
of 4 years led us to relate them to the duration of renal failure and the
duration of RTD. Aside from the latent subcutaneous deposits, which
should be investigated by systematic biopsy, spontaneous hemarthrosis
and bleeding from the ileum must be recognized as two clinical
manifestations of AML in patients on RTD. The absence of a carpal
tunnel syndrome in patients on RTD does not eliminate amyloid
disease. In this case, the Wright technique supports the non-
immunoglobulin-induced (AA) amyloidosis nature.
